Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips (PHG) and Spencer's joint digital solution, which improves medication adherence in patients in the United States, is set to hit select European markets.

Philips & Spencer Health to Extend Joint Solution to Europe

Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients

Philips and Spencer Health Solutions expand partnership to Europe

Shares of Philips Electronics PHIA, -8.33% tumbled 8% in early Amsterdam as the company issued a warning over its connected care business, which had a 4.5-point decline in its adjusted margin during the third quarter.

Philips shares slump as connected-care business hit by tariffs

Philips provides update on its financial performance in Q3 2019

Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon

Amsterdam, the Netherlands and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its commitment to improving care for hundreds of millions of patients worldwide living with chronic sleep and respiratory conditions in its 17th appearance at the European Respiratory Society (ERS) International Congress, taking place September 28 - October 2, 2019, in Madrid, Spain.

Philips showcases commitment to improving respiratory care at ERS 2019

Philips announces availability of expanded SmartSleep suite of solutions in U.S. market

Philips underlines commitment to Universal Health Coverage at UNGA 74

Philips teams up with PURE on pioneering tele-ultrasound program linking specialists around the globe with physicians in Rwanda

Philips launches NightBalance, increasing therapy options for positional obstructive sleep apnea patients

Philips maintains its top ranking in the Dow Jones Sustainability Indices

Philips Global Beauty Index reveals that women want personalized beauty solutions to meet their unique needs

Philips showcases integrated radiation oncology portfolio to provide a confident path to treatment at ASTRO 2019

Philips and B. Braun launch Onvision needle tip tracking, a breakthrough in real-time ultrasound guidance for regional anesthesia

Philips’ intelligent health solutions at IFA 2019 adapt to individual consumer needs

Apple

Fitbit

Alphabet

Garmin

Personal healthcare market is booming on expanding initiatives by tech giants like Apple (AAPL), Fitbit (FIT) and Alphabet (GOOGL), to name a few.

Tech Taking Personal Healthcare by Storm: Stocks in Focus

Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019

Daniela Seabrook to succeed Ronald de Jong as Philips’ Chief Human Resources Officer

Periodic update on transaction details related to Philips’ share repurchases

Philips signs agreement to create Taiwan’s first fully digitalized pathology department

Healthcare giant Philips was warned of suspicious sales of its medical equipment to the Brazilian government, and failed to halt them, nearly a decade before an alleged bribery racket was exposed in the company's Brazil operations last year, Reuters has learned.

Philips, under investigation in U.S. and Brazil, fired whistleblower who warned of graft

Exclusive: Philips, under investigation in U.S. and Brazil, fired whistleblower who warned of graft

Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide

Koninklijke Philips' (PHG) second-quarter results benefit from robust performance in the Diagnosis & Treatment business.

Koninklijke Philips' (PHG) Q2 Earnings & Sales Rise Y/Y

News for Royal Philips Stock (PHG)